Target intelligence / Profile preview

Microbial cell membranes and biofilm matrix components

Molecular classification
Other, Cellular structural component
01

Overview

Microbial cell membranes and biofilm matrix components represent broad, non-specific therapeutic targets for antimicrobial agents. The microbial cell membrane is a vital phospholipid bilayer that maintains cellular homeostasis and regulates the transport of ions and nutrients (Zasloff, 2002, Nature). In many chronic infections, microbes reside within a biofilm matrix—a complex assembly of extracellular polymeric substances (EPS) including polysaccharides, proteins, and DNA—which provides structural stability and protection against host immune responses and antibiotics (Flemming & Wingender, 2010, Nature Reviews Microbiology). Drugs targeting these components, such as antiseptics like chlorhexidine and certain lipopeptide antibiotics like daptomycin, act by physically disrupting the membrane or chemically degrading the matrix (McDonnell & Russell, 1999, Clinical Microbiology Reviews). This non-specific approach is particularly effective against multi-drug resistant organisms because it bypasses specific metabolic pathways that bacteria often mutate to gain resistance. However, the lack of specificity can sometimes lead to host cell toxicity, necessitating careful clinical application (StatPearls, 2023).

Other names
Microbial cell envelopeExtracellular polymeric substances (EPS)Biofilm matrixBacterial cell membraneFungal cell membrane
02

Mechanism of action

Non-specific disruption of the lipid bilayer, denaturation of membrane-bound proteins, and oxidative degradation of extracellular polymeric substances (EPS) within the biofilm matrix, leading to loss of cellular homeostasis and cell death (McDonnell & Russell, 1999, Clinical Microbiology Reviews).

03

Biological functions

Structural integrityPermeability barrierCellular protectionAdhesionNutrient sequestration
04

Disease associations

InfectionBiofilm-associated infectionSepsisWound infection
05

Safety considerations

Host tissue cytotoxicity (StatPearls, 2023)Systemic toxicity such as nephrotoxicity with polymyxins (PubMed, 2021)Delayed wound healingSkin irritation
06

Interacting drugs

Chlorhexidine

7 more in the full profile.

07

Biomarkers

Microbial load (CFU/mL)Biofilm thickness (NIH, 2022)ProcalcitoninC-reactive protein

Beyond the preview

Go deeper on Microbial cell membranes and biofilm matrix components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial cell membranes and biofilm matrix components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call